MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30. 6., 22:00:00 GMT+2 · EUR
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
CNBC
·
před 1 hodinou
The perfect storm behind the Nasdaq's rout — plus, some of the bright spots in the market
The Motley Fool
·
před 22 minutami
The Stock Market Sounds an Alarm for the First Time in Nearly 27 Years. Here Is What History Says the S&P 500 Will Do Next.
Markets Media
·
před 34 minutami
Nasdaq Advances Shift Towards More Connected Always-On Markets
Seeking Alpha
·
před 47 minutami
Bad Day, Decent Breadth
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia